DEA Places Certain CBD-Containing FDA-Approved Drugs in Schedule V of Controlled Substances Act

Summary

The Drug Enforcement Administration has issued a final order placing FDA-approved drugs containing cannabidiol derived from cannabis and no more than 0.1 percent tetrahydrocannabinols in schedule V of the Controlled Substances Act, requiring a permit for import or export.